APO Research
Talk to an analyst

APO RESEARCH · REPORT

Equine Healthcare

Equine health refers to veterinary services intended to treat horses to enhance their quality of life. The equine healthcare market is an emerging field of pharmaceuticals.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Equine health refers to veterinary services intended to treat horses to enhance their quality of life. The equine healthcare market is an emerging field of pharmaceuticals.

Selected research

Market Outlook & Growth Opportunities

Global Equine Healthcare Market Outlook and Growth Opportunities 2026

1 January 2026197 pages

Choose your research edition.

Industry ResearchEquine Healthcare Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Equine Healthcare Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Equine Healthcare Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Equine Healthcare Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Equine Healthcare Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Equine health refers to veterinary services intended to treat horses to enhance their quality of life. The equine healthcare market is an emerging field of pharmaceuticals.

The top 13 manufacturers held about 75.03% of the market share in 2019.

This report provides an overview of the global Equine Healthcare market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Equine Healthcare and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Equine Healthcare revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Equine Healthcare market.

Equine Healthcare Segment by Company

Boehringer Ingelheim

Merck Animal Health

Zoetis

Bayer Animal Health

Elanco Animal Health

Ceva Animal Health

Dechra Veterinary Products

Purina Mills

Norbrook Equine

Virbac

Kyoritsu Seiyaku

Vetoquinol

Protexin Healthcare

Equine Healthcare Segment by Type

Equine Diagnostic Products

Equine Therapeutic Products

Equine Supplement Products

Equine Healthcare Segment by Application

Veterinary Hospitals and Clinics

Retail Pharmacies and Drug Stores

Others

Equine Healthcare Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Equine Healthcare status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Equine Healthcare key companies, revenue, market share, and recent developments.

3. To split the Equine Healthcare breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Equine Healthcare market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Equine Healthcare significant trends, drivers, influence factors in global and regions.

6. To analyze Equine Healthcare competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Healthcare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Equine Healthcare and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Healthcare.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Equine Healthcare industry.

Chapter 3: Detailed analysis of Equine Healthcare company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Equine Healthcare in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Equine Healthcare in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Equine Healthcare Industry Trends Table 2. Equine Healthcare Industry Drivers Table 3. Equine Healthcare Industry Opportunities and Challenges Table 4. Equine Healthcare Industry Restraints Table 5. Global Equine Healthcare Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Equine Healthcare Revenue Share by Company (2021-2026) Table 7. Global Equine Healthcare Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Equine Healthcare Key Company Manufacturing Base & Headquarters Table 9. Global Equine Healthcare Company, Product Type & Application Table 10. Global Equine Healthcare Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Equine Healthcare by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Equine Diagnostic Products Table 15. Significant Companies of Equine Therapeutic Products Table 16. Significant Companies of Equine Supplement Products Table 17. Global Equine Healthcare Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Equine Healthcare Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Equine Healthcare Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Equine Healthcare Sales Value Share by Type (2021-2026) Table 21. Global Equine Healthcare Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Veterinary Hospitals and Clinics Table 23. Significant Companies of Retail Pharmacies and Drug Stores Table 24. Significant Companies of Others Table 25. Global Equine Healthcare Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Equine Healthcare Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Equine Healthcare Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Equine Healthcare Sales Value Share by Application (2021-2026) Table 29. Global Equine Healthcare Sales Value Share by Application (2027-2032) Table 30. Global Equine Healthcare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Equine Healthcare Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Equine Healthcare Sales Value Share by Region (2021-2026) Table 33. Global Equine Healthcare Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Equine Healthcare Sales Value Share by Region (2027-2032) Table 35. Global Equine Healthcare Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Equine Healthcare Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Equine Healthcare Sales Value Market Share by Country (2021-2026) Table 38. Global Equine Healthcare Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Equine Healthcare Sales Value Market Share by Country (2027-2032) Table 40. Boehringer Ingelheim Company Information Table 41. Boehringer Ingelheim Business Overview Table 42. Boehringer Ingelheim Equine Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Boehringer Ingelheim Equine Healthcare Product Portfolio Table 44. Boehringer Ingelheim Recent Development Table 45. Merck Animal Health Company Information Table 46. Merck Animal Health Business Overview Table 47. Merck Animal Health Equine Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Merck Animal Health Equine Healthcare Product Portfolio Table 49. Merck Animal Health Recent Development Table 50. Zoetis Company Information Table 51. Zoetis Business Overview Table 52. Zoetis Equine Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Zoetis Equine Healthcare Product Portfolio Table 54. Zoetis Recent Development Table 55. Bayer Animal Health Company Information Table 56. Bayer Animal Health Business Overview Table 57. Bayer Animal Health Equine Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Bayer Animal Health Equine Healthcare Product Portfolio Table 59. Bayer Animal Health Recent Development Table 60. Elanco Animal Health Company Information Table 61. Elanco Animal Health Business Overview Table 62. Elanco Animal Health Equine Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Elanco Animal Health Equine Healthcare Product Portfolio Table 64. Elanco Animal Health Recent Development Table 65. Ceva Animal Health Company Information Table 66. Ceva Animal Health Business Overview Table 67. Ceva Animal Health Equine Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Ceva Animal Health Equine Healthcare Product Portfolio Table 69. Ceva Animal Health Recent Development Table 70. Dechra Veterinary Products Company Information Table 71. Dechra Veterinary Products Business Overview Table 72. Dechra Veterinary Products Equine Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Dechra Veterinary Products Equine Healthcare Product Portfolio Table 74. Dechra Veterinary Products Recent Development Table 75. Purina Mills Company Information Table 76. Purina Mills Business Overview Table 77. Purina Mills Equine Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Purina Mills Equine Healthcare Product Portfolio Table 79. Purina Mills Recent Development Table 80. Norbrook Equine Company Information Table 81. Norbrook Equine Business Overview Table 82. Norbrook Equine Equine Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Norbrook Equine Equine Healthcare Product Portfolio Table 84. Norbrook Equine Recent Development Table 85. Virbac Company Information Table 86. Virbac Business Overview Table 87. Virbac Equine Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Virbac Equine Healthcare Product Portfolio Table 89. Virbac Recent Development Table 90. Kyoritsu Seiyaku Company Information Table 91. Kyoritsu Seiyaku Business Overview Table 92. Kyoritsu Seiyaku Equine Healthcare Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 93. Kyoritsu Seiyaku Equine Healthcare Product Portfolio Table 94. Kyoritsu Seiyaku Recent Development Table 95. Vetoquinol Company Information Table 96. Vetoquinol Business Overview Table 97. Vetoquinol Equine Healthcare Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 98. Vetoquinol Equine Healthcare Product Portfolio Table 99. Vetoquinol Recent Development Table 100. Protexin Healthcare Company Information Table 101. Protexin Healthcare Business Overview Table 102. Protexin Healthcare Equine Healthcare Sales (), Value (US$ Million), Price () and Gross Margin (2021-2026) Table 103. Protexin Healthcare Equine Healthcare Product Portfolio Table 104. Protexin Healthcare Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Equine Healthcare Product Image Figure 2. Global Equine Healthcare Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Equine Healthcare Market Size (2021-2032) & (US$ Million) Figure 4. Global Equine Healthcare Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Equine Diagnostic Products Image Figure 8. Equine Therapeutic Products Image Figure 9. Equine Supplement Products Image Figure 10. Global Equine Healthcare Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Equine Healthcare Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Equine Healthcare Sales Value Share by Type (2021-2032) Figure 13. Veterinary Hospitals and Clinics Image Figure 14. Retail Pharmacies and Drug Stores Image Figure 15. Others Image Figure 16. Global Equine Healthcare Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Equine Healthcare Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Equine Healthcare Sales Value Share by Application (2021-2032) Figure 19. Global Equine Healthcare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Equine Healthcare Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Equine Healthcare Sales Value (2021-2032) & (US$ Million) Figure 22. North America Equine Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Equine Healthcare Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Equine Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Equine Healthcare Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Equine Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Equine Healthcare Sales Value (2021-2032) & (US$ Million) Figure 28. South America Equine Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Equine Healthcare Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Equine Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Equine Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Equine Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Equine Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Equine Diagnostic Products
  • Equine Therapeutic Products
  • Equine Supplement Products
Applications
  • Veterinary Hospitals and Clinics
  • Retail Pharmacies and Drug Stores
  • Others
Companies covered
  • Boehringer Ingelheim
  • Merck Animal Health
  • Zoetis
  • Bayer Animal Health
  • Elanco Animal Health
  • Ceva Animal Health
  • Dechra Veterinary Products
  • Purina Mills
  • Norbrook Equine
  • Virbac
  • Kyoritsu Seiyaku
  • Vetoquinol
  • Protexin Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Equine Healthcare Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Equine Healthcare Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Equine Healthcare Market Dynamics
  1. 2.1 Equine Healthcare Industry Trends
  2. 2.2 Equine Healthcare Industry Drivers
  3. 2.3 Equine Healthcare Industry Opportunities and Challenges
  4. 2.4 Equine Healthcare Industry Restraints
3 Equine Healthcare Market by Company
  1. 3.1 Global Equine Healthcare Company Revenue Ranking in 2025
  2. 3.2 Global Equine Healthcare Revenue by Company (2021-2026)
  3. 3.3 Global Equine Healthcare Company Ranking (2024-2026)
  4. 3.4 Global Equine Healthcare Company Manufacturing Base and Headquarters
  5. 3.5 Global Equine Healthcare Company Product Type and Application
  6. 3.6 Global Equine Healthcare Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Equine Healthcare Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Equine Healthcare Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Equine Healthcare Market by Type
  1. 4.1 Equine Healthcare Type Introduction
  2. 4.1.1 Equine Diagnostic Products
  3. 4.1.2 Equine Therapeutic Products
  4. 4.1.3 Equine Supplement Products
  5. 4.2 Global Equine Healthcare Sales Value by Type
  6. 4.2.1 Global Equine Healthcare Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Equine Healthcare Sales Value by Type (2021-2032)
  8. 4.2.3 Global Equine Healthcare Sales Value Share by Type (2021-2032)
5 Equine Healthcare Market by Application
  1. 5.1 Equine Healthcare Application Introduction
  2. 5.1.1 Veterinary Hospitals and Clinics
  3. 5.1.2 Retail Pharmacies and Drug Stores
  4. 5.1.3 Others
  5. 5.2 Global Equine Healthcare Sales Value by Application
  6. 5.2.1 Global Equine Healthcare Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Equine Healthcare Sales Value by Application (2021-2032)
  8. 5.2.3 Global Equine Healthcare Sales Value Share by Application (2021-2032)
6 Equine Healthcare Regional Value Analysis
  1. 6.1 Global Equine Healthcare Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Equine Healthcare Sales Value by Region (2021-2032)
  3. 6.2.1 Global Equine Healthcare Sales Value by Region: 2021-2026
  4. 6.2.2 Global Equine Healthcare Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Equine Healthcare Sales Value (2021-2032)
  7. 6.3.2 North America Equine Healthcare Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Equine Healthcare Sales Value (2021-2032)
  10. 6.4.2 Europe Equine Healthcare Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Equine Healthcare Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Equine Healthcare Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Equine Healthcare Sales Value (2021-2032)
  16. 6.6.2 South America Equine Healthcare Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Equine Healthcare Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Equine Healthcare Sales Value Share by Country, 2025 VS 2032
7 Equine Healthcare Country-level Value Analysis
  1. 7.1 Global Equine Healthcare Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Equine Healthcare Sales Value by Country (2021-2032)
  3. 7.2.1 Global Equine Healthcare Sales Value by Country (2021-2026)
  4. 7.2.2 Global Equine Healthcare Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Equine Healthcare Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Equine Healthcare Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Equine Healthcare Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Equine Healthcare Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Equine Healthcare Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Equine Healthcare Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Equine Healthcare Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Equine Healthcare Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Equine Healthcare Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Equine Healthcare Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Equine Healthcare Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Equine Healthcare Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Equine Healthcare Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Equine Healthcare Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Equine Healthcare Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Equine Healthcare Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Equine Healthcare Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Equine Healthcare Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Equine Healthcare Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Equine Healthcare Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Equine Healthcare Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Equine Healthcare Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Equine Healthcare Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Equine Healthcare Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Equine Healthcare Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Equine Healthcare Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Equine Healthcare Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Equine Healthcare Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Equine Healthcare Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Equine Healthcare Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Equine Healthcare Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Equine Healthcare Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Equine Healthcare Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Merck Animal Health
  8. 8.2.1 Merck Animal Health Company Information
  9. 8.2.2 Merck Animal Health Business Overview
  10. 8.2.3 Merck Animal Health Equine Healthcare Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Animal Health Equine Healthcare Product Portfolio
  12. 8.2.5 Merck Animal Health Recent Developments
  13. 8.3 Zoetis
  14. 8.3.1 Zoetis Company Information
  15. 8.3.2 Zoetis Business Overview
  16. 8.3.3 Zoetis Equine Healthcare Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Zoetis Equine Healthcare Product Portfolio
  18. 8.3.5 Zoetis Recent Developments
  19. 8.4 Bayer Animal Health
  20. 8.4.1 Bayer Animal Health Company Information
  21. 8.4.2 Bayer Animal Health Business Overview
  22. 8.4.3 Bayer Animal Health Equine Healthcare Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Animal Health Equine Healthcare Product Portfolio
  24. 8.4.5 Bayer Animal Health Recent Developments
  25. 8.5 Elanco Animal Health
  26. 8.5.1 Elanco Animal Health Company Information
  27. 8.5.2 Elanco Animal Health Business Overview
  28. 8.5.3 Elanco Animal Health Equine Healthcare Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Elanco Animal Health Equine Healthcare Product Portfolio
  30. 8.5.5 Elanco Animal Health Recent Developments
  31. 8.6 Ceva Animal Health
  32. 8.6.1 Ceva Animal Health Company Information
  33. 8.6.2 Ceva Animal Health Business Overview
  34. 8.6.3 Ceva Animal Health Equine Healthcare Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ceva Animal Health Equine Healthcare Product Portfolio
  36. 8.6.5 Ceva Animal Health Recent Developments
  37. 8.7 Dechra Veterinary Products
  38. 8.7.1 Dechra Veterinary Products Company Information
  39. 8.7.2 Dechra Veterinary Products Business Overview
  40. 8.7.3 Dechra Veterinary Products Equine Healthcare Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Dechra Veterinary Products Equine Healthcare Product Portfolio
  42. 8.7.5 Dechra Veterinary Products Recent Developments
  43. 8.8 Purina Mills
  44. 8.8.1 Purina Mills Company Information
  45. 8.8.2 Purina Mills Business Overview
  46. 8.8.3 Purina Mills Equine Healthcare Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Purina Mills Equine Healthcare Product Portfolio
  48. 8.8.5 Purina Mills Recent Developments
  49. 8.9 Norbrook Equine
  50. 8.9.1 Norbrook Equine Company Information
  51. 8.9.2 Norbrook Equine Business Overview
  52. 8.9.3 Norbrook Equine Equine Healthcare Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Norbrook Equine Equine Healthcare Product Portfolio
  54. 8.9.5 Norbrook Equine Recent Developments
  55. 8.10 Virbac
  56. 8.10.1 Virbac Company Information
  57. 8.10.2 Virbac Business Overview
  58. 8.10.3 Virbac Equine Healthcare Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Virbac Equine Healthcare Product Portfolio
  60. 8.10.5 Virbac Recent Developments
  61. 8.11 Kyoritsu Seiyaku
  62. 8.11.1 Kyoritsu Seiyaku Company Information
  63. 8.11.2 Kyoritsu Seiyaku Business Overview
  64. 8.11.3 Kyoritsu Seiyaku Equine Healthcare Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Kyoritsu Seiyaku Equine Healthcare Product Portfolio
  66. 8.11.5 Kyoritsu Seiyaku Recent Developments
  67. 8.12 Vetoquinol
  68. 8.12.1 Vetoquinol Company Information
  69. 8.12.2 Vetoquinol Business Overview
  70. 8.12.3 Vetoquinol Equine Healthcare Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Vetoquinol Equine Healthcare Product Portfolio
  72. 8.12.5 Vetoquinol Recent Developments
  73. 8.13 Protexin Healthcare
  74. 8.13.1 Protexin Healthcare Company Information
  75. 8.13.2 Protexin Healthcare Business Overview
  76. 8.13.3 Protexin Healthcare Equine Healthcare Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Protexin Healthcare Equine Healthcare Product Portfolio
  78. 8.13.5 Protexin Healthcare Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst